In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.

Henry C Barry
Author Information

Abstract

No abstract text available.

Word Cloud

Created with Highcharts 10.0.0OlderAdultsType2DiabetesGLP-1ReceptorAgonistsDecreaseMajorAdverseCardiovascularEventsSGLT-2InhibitorsPreventHeartFailureHospitalizations

Similar Articles

Cited By

No available data.